MIP Diagnostics Press Releases

• Published on April 4, 2023 - 10:01 GMT

  

  MIP Discovery announces drugs of abuse reagent launch

  Novel nanoMIP affinity reagents engineered to recognise metabolites of the synthetic opioid, fentanyl are now available for research evaluation. BEDFORD, BEDFORDSHIRE, UK, April 4, 2023 /⁨EINPresswire.com⁩/ -- Novel nanoMIP affinity reagents engineered …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on May 24, 2022 - 09:20 GMT

  

  MIP Discovery Adopts the Fida 1 Platform

  The FIDA technology enables MIP Discovery to offer Molecularly Imprinted Polymers of unmatched quality. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, May 24, 2022 /⁨EINPresswire.com⁩/ -- MIP Discovery today announced the adoption of the Fida 1 platform into it …

  Distribution channels: Chemical Industry, Companies ...
• Published on May 18, 2022 - 09:10 GMT

  

  Rapidly growing nanotechnology firm launches new identity as MIP Discovery

  MIP Diagnostics, a leading UK nanotechnology firm has today rebranded to MIP Discovery as the business continues its expansion within the healthcare sector. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, May 18, 2022 /⁨EINPresswire.com⁩/ -- Bedfordshire based MIP …

  Distribution channels: Business & Economy, Companies ...
• Published on March 8, 2022 - 09:35 GMT

  

  MIP Diagnostics announces the appointment of Michele Pedrocchi to its Board

  MIP Diagnostics Ltd. has appointed, Michele Pedrocchi, an experienced international Life Science Executive, to its board of directors. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, March 8, 2022 /⁨EINPresswire.com⁩/ -- MIP Diagnostics Ltd. has appointed, …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on March 3, 2022 - 09:30 GMT

  

  MIP Diagnostics appoints Mike Evans to Chairman of the Board

  MIP Diagnostics Ltd. has announced that Jim Reid is retiring from his position as Chairman of the board, and the company has appointed Mike Evans, to the role. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, March 3, 2022 /⁨EINPresswire.com⁩/ -- MIP Diagnostics …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on March 1, 2022 - 08:00 GMT

  

  MIP Diagnostics secures £7.3M investment following achievement of critical milestones

  Mercia Asset Management, Calculus Capital, Downing Ventures and BGF scale joint investment in latest fundraise BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, March 1, 2022 /⁨EINPresswire.com⁩/ -- MIP Diagnostics, a UK nanotechnology business has secured increased …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on January 13, 2022 - 15:01 GMT

  

  Synthetic antibody demonstrates Omicron detection along with all other variants of concern

  MIP Diagnostics' synthetic SARS-CoV-2 antibody shown to detect the Omicron variant as well as previously proven Alpha, Beta, Delta and Gamma variants BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, January 13, 2022 /⁨EINPresswire.com⁩/ -- MIP Diagnostics Ltd. …

  Distribution channels: Business & Economy, Chemical Industry ...
• Published on October 26, 2021 - 11:39 GMT

  

  MIP Diagnostics to support the development of challenging affinity reagents with Molecular Imprinting Epitope Discovery

  MIP Diagnostics, has today launched its new Molecular Imprinting Epitope Discovery Service for the identification of previously unknow protein surface epitopes. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, October 26, 2021 /⁨EINPresswire.com⁩/ -- MIP …

  Distribution channels: Chemical Industry, Companies ...
• Published on October 4, 2021 - 16:49 GMT

  

  Ulster university selects MIP Diagnostics COVID-19 nanoMIP for its NANOCUBE sensor

  Dr Nikhil Bhalla’s research group at Ulster University has selected MIP Diagnostics COVID-19 nanoMIP for integration into its NANOCUBE sensor device. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, October 4, 2021 /⁨EINPresswire.com⁩/ -- Dr Nikhil Bhalla’s …

  Distribution channels: Chemical Industry, Companies ...
• Published on July 19, 2021 - 11:12 GMT

  

  Soterius selects MIP Diagnostics’ synthetic antibodies for rapid COVID-19 biosensor

  Soterius, an Australian medical device start-up has selected MIP Diagnostics for the affinity reagent in its novel COVID-19 biosensor. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, July 19, 2021 /⁨EINPresswire.com⁩/ -- Soterius, an Australian medical device …

  Distribution channels: Companies, Electronics Industry ...
• Published on June 22, 2021 - 13:46 GMT

  

  MIP Diagnostics’ COVID-19 nanoMIP offers significantly improved sensitivity to antibodies in a diagnostic sensor

  MIP Diagnostics' COVID-19 nanoMIP outperforms commercial antibodies in a sensor platform, which could enable improved detection of lower viral loads. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, June 22, 2021 /⁨EINPresswire.com⁩/ -- MIP Diagnostics Ltd. …

  Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
• Published on May 4, 2021 - 11:53 GMT

  

  MIP Diagnostics continues 2021 success with ISO 9001 accreditation

  MIP Diagnostics demonstrates commitment to quality and customer satisfaction with ISO 9001:2015 certification BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, May 4, 2021 /⁨EINPresswire.com⁩/ -- MIP Diagnostics, a UK manufacturer of molecularly imprinted polymers ( …

  Distribution channels: Business & Economy, Companies ...
• Published on April 20, 2021 - 10:38 GMT

  

  Synthetic antibody offers ultra-high sensitivity for next wave of COVID-19 sensors

  MIP Diagnostics launches its COVID-19 nanoMIP for diagnostic sensors, a synthetic alternative to Abs with ultra-high sensitivity for the next wave of tests. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, April 20, 2021 /⁨EINPresswire.com⁩/ -- MIP Diagnostics Ltd. …

  Distribution channels: Business & Economy, Chemical Industry ...